Genmab A/S (GMAB)
19.51
0.19 (0.98%)
At close: Apr 15, 2025, 3:59 PM
19.58
0.34%
After-hours: Apr 15, 2025, 05:18 PM EDT
Genmab A/S Analyst Ratings
Total Analysts
9
Consensus Rating
Buy
Price Target
41
Upside
110.15
Ratings History
| Analyst | Firm | Rating | Action | Price Target | Upside | Date |
| HC Wainwright & Co. | Buy | Reiterates | 50 37 | 89.65% | Apr 9, 2025 | |
| Truist Securities | Buy | Maintains | 50 45 | 130.65% | Mar 11, 2025 | |
| William Blair | Buy | Upgrades | n/a | n/a | Mar 11, 2025 |
Stop Guessing, Start Knowing.
Cut through market noise with actionable insights that actually help you make confident investment decisions. No more endless research or gut-based guessing.
- Unlimited access to all data and tools
- Unlimited access to all data and tools, giving you the edge over everyone else in the market.
- Realtime Options & Dark Pool Data
- Instant access to live options & dark pool data to spot opportunities and trade with precision before the market moves.
- Top Wallstreet Analyst Ratings
- Follow ratings from the best analysts on Wall Street to stay ahead.
- Up to 30 years financial history
- We deliver premium Wall Street data with top-tier accuracy and up to 30 years of history.
Analyst Star Rankings
Our analyst star rankings are based on these four factors
- Success Rate
- The percentage of ratings that are profitable.
- Average Return
- The average percentage return within one year of the rating.
- Rating Count
- The more ratings the analyst has provided, the higher the score.
- Recency
- Ratings provided within the past year contribute to a higher score.